Search Results - "Ariens, R."

Refine Results
  1. 1
  2. 2

    Subunit Antigen and Activity Levels of Blood Coagulation Factor XIII in Healthy Individuals: Relation to Sex, Age, Smoking, and Hypertension by Ariëns, R A.S, Kohler, H P, Mansfield, M W, Grant, P J

    “…Factor (F) XIII covalently cross-links and stabilizes the fibrin-clot. Recent evidence suggests a role for FXIII in atherothrombotic diseases, but no…”
    Get full text
    Journal Article
  3. 3

    Fibrin(ogen) and thrombotic disease by Ariëns, R. A. S.

    Published in Journal of thrombosis and haemostasis (01-06-2013)
    “…Summary Fibrinogen is an abundant plasma protein that, when converted to fibrin by thrombin, provides the main building blocks for the clot. Dys‐, a‐, and…”
    Get full text
    Journal Article
  4. 4

    Dysfibrinogenemia: from molecular anomalies to clinical manifestations and management by Casini, A., Neerman‐Arbez, M., Ariëns, R. A., Moerloose, P.

    Published in Journal of thrombosis and haemostasis (01-06-2015)
    “…Summary Congenital dysfibrinogenemia is a qualitative congenital fibrinogen disorder characterized by normal antigen levels of a dysfunctional fibrinogen. The…”
    Get full text
    Journal Article
  5. 5

    The effect of blood coagulation factor XIII on fibrin clot structure and fibrinolysis by Hethershaw, E. L., Cilia La Corte, A. L., Duval, C., Ali, M., Grant, P. J., Ariëns, R. A. S., Philippou, H.

    Published in Journal of thrombosis and haemostasis (01-02-2014)
    “…Summary Background Factor XIII is a 320 kDa tetramer, comprising two enzymatic A‐subunits and two carrier B‐subunits (FXIII A2B2). Activated FXIII (FXIIIa)…”
    Get full text
    Journal Article
  6. 6

    Procoagulant changes in fibrin clot structure in patients with cirrhosis are associated with oxidative modifications of fibrinogen by Hugenholtz, G. C. G., Macrae, F., Adelmeijer, J., Dulfer, S., Porte, R. J., Lisman, T., Ariëns, R. A. S.

    Published in Journal of thrombosis and haemostasis (01-05-2016)
    “…Essentials Patients with cirrhosis have hemostatic changes, which may contribute to a risk of thrombosis. This in vitro study compares clot formation and…”
    Get full text
    Journal Article
  7. 7

    Neutrophils can promote clotting via FXI and impact clot structure via neutrophil extracellular traps in a distinctive manner in vitro by Shi, Y., Gauer, J. S., Baker, S. R., Philippou, H., Connell, S. D., Ariëns, R. A. S.

    Published in Scientific reports (18-01-2021)
    “…Neutrophils and neutrophil extracellular traps (NETs) have been shown to be involved in coagulation. However, the interactions between neutrophils or NETs and…”
    Get full text
    Journal Article
  8. 8

    In vitro batch fermentation of (un)saturated homogalacturonan oligosaccharides by Zwolschen, J W, Vos, A P, Ariëns, R M C, Schols, H A

    Published in Carbohydrate polymers (01-04-2024)
    “…Pectin, predominantly present within plant cell walls, is a dietary fiber that potentially induces distinct health effects depending on its molecular…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Ex vivo addition of fibrinogen concentrate improves the fibrin network structure in plasma samples taken during liver transplantation by Groeneveld, D. J., Adelmeijer, J., Hugenholtz, G. C. G., Ariëns, R. A. S., Porte, R. J., Lisman, T.

    Published in Journal of thrombosis and haemostasis (01-12-2015)
    “…Summary Background Optimal hemostatic management during orthotopic liver transplantation (OLT) remains a challenge. The cause of bleeding during OLT is…”
    Get full text
    Journal Article
  11. 11

    Principles of some novel rapid dipstick methods for detection and characterization of verotoxigenic Escherichia coli by Aldus, C.F., Van Amerongen, A., Ariëns, R.M.C., Peck, M.W., Wichers, J.H., Wyatt, G.M.

    Published in Journal of applied microbiology (01-01-2003)
    “…Aims: The verotoxigenic Escherichia coli (VTEC) serotype most commonly associated with verotoxin (VT) production is O157:H7, but other serotypes have also been…”
    Get full text
    Journal Article
  12. 12

    Fibrin clot structure in patients with congenital dysfibrinogenaemia by Casini, A, Duval, C, Pan, X, Tintillier, V, Biron-Andreani, C, Ariëns, R.A.S

    Published in Thrombosis research (01-01-2016)
    “…Abstract The clinical phenotype of patients with congenital dysfibrinogenaemia is highly heterogeneous, from absence of symptoms to mild bleeding, or…”
    Get full text
    Journal Article
  13. 13

    Evidence that fibrinogen γ′ directly interferes with protofibril growth: implications for fibrin structure and clot stiffness by ALLAN, P., UITTE de WILLIGE, S., ABOU‐SALEH, R. H., CONNELL, S. D., ARIËNS, R. A. S.

    Published in Journal of thrombosis and haemostasis (01-06-2012)
    “…Background:  Fibrinogen contains an alternatively spliced γ‐chain (γ′), which mainly exists as a heterodimer with the common γA‐chain (γA/γ′). Fibrinogen γ′…”
    Get full text
    Journal Article
  14. 14

    The influence of type 2 diabetes on fibrin structure and function by DUNN, E. J, ARIËNS, R. A. S, GRANT, P. J

    Published in Diabetologia (01-06-2005)
    “…The precise mechanisms underlying the increased risk of cardiovascular disease (CVD) in type 2 diabetes are unclear. Fibrin clot structure has been related to…”
    Get full text
    Journal Article
  15. 15

    International Stakeholder Community of Pain Experts and Leaders Call for an Urgent Action on Forced Opioid Tapering by Darnall, Beth D, Kerns, Robert D, Van Dorsten, Brent, Humphreys, Keith, Gonzalez-Sotomayor, Julio A, Furlan, Andrea, Gordon, Adam J, Gordon, Debra B, Hoffman, Diane E, Katz, Joel, Kertesz, Stefan G, Satel, Sally, Lawhern, Richard A, Nicholson, Kate M, Polomano, Rosemary C, Williamson, Owen D, McAnally, Heath, Kao, Ming-Chih, Schug, Stephan, Twillman, Robert, Lewis, Terri A, Stieg, Richard L, Lorig, Kate, Mallick-Searle, Theresa, West, Robert W, Gray, Sarah, Ariens, Steven R, Sharpe Potter, Jennifer, Cowan, Penney, Kollas, Chad D, Laird, Danial, Ingle, Barby, Julian Grove, J, Wilson, Marian, Lockman, Kashelle, Hodson, Fiona, Palackdharry, Carol S, Fillingim, Roger B, Fudin, Jeffrey, Barnhouse, Jennifer, Manhapra, Ajay, Henson, Steven R, Singer, Bruce, Ljosenvoor, Marie, Griffith, Marlisa, Doctor, Jason N, Hardin, Kimeron, London, Cathleen, Mankowski, Jon, Anderson, Andrea, Ellsworth, Linda, Davis Budzinski, Lisa, Brandt, Becky, Hartley, Greg, Nickels Heck, Debbie, Zobrosky, Mark J, Cheek, Celeste, Wilson, Megan, Laux, Cynthia E, Datz, Geralyn, Dunaway, Justin, Schonfeld, Eileen, Cady, Melissa, LeDantec-Boswell, Thérèse, Craigie, Meredith, Sturgeon, John, Flood, Pamela, Giummarra, Melita, Whelan, Jessica, Thorn, Beverly E, Martin, Richard L, Schatman, Michael E, Gregory, Maurice D, Kirz, Joshua, Robinson, Patti, Marx, James G, Stewart, Jessica R, Hadland, Scott E, Murphy, Jennifer L, Lumley, Mark A, Brown, Kathleen S, Leong, Michael S, Fillman, Mechele, Perez, Aaron, Watford, Kristine, Kruska, Kari, Sophia You, Dokyoung, Ogbeide, Stacy, Kukucka, Amy, Lawson, Susan, Ray, James B, Wade Martin, T, Lakehomer, James B, Burke, Anne, Cohen, Robert I, Grinspoon, Peter, Rubenstein, Marc S, Sutherland, Stephani, Walters, Kristie, Lovejoy, Travis

    Published in Pain medicine (Malden, Mass.) (01-03-2019)
    “…We, the undersigned, stand as a unified community of stakeholders and key opinion leaders deeply concerned about forced opioid tapering in patients receiving…”
    Get full text
    Journal Article
  16. 16

    Molecular mechanisms involved in the resistance of fibrin to clot lysis by plasmin in subjects with type 2 diabetes mellitus by DUNN, E. J, PHILIPPOU, H, ARIËNS, R. A. S, GRANT, P. J

    Published in Diabetologia (01-05-2006)
    “…The aim of this study was to determine the influence of type 2 diabetes on fibrinolysis by assessing interactions between the regulatory components of…”
    Get full text
    Journal Article
  17. 17
  18. 18

    Effects of Aspirin on Clot Structure and Fibrinolysis Using a Novel In Vitro Cellular System by AJJAN, R. A, STANDEVEN, K. F, KHANBHAI, M, PHOENIX, F, GERSH, K. C, WEISEL, J. W, KEARNEY, M. T, ARIËNS, R. A. S, GRANT, P. J

    “…The purpose of this study was to investigate the direct effects of aspirin on fibrin structure/function. Chinese Hamster Ovary cell lines stably transfected…”
    Get full text
    Journal Article
  19. 19

    Inhibition of thrombin‐mediated factor V activation contributes to the anticoagulant activity of fibrinogen γ by Omarova, F., Uitte De Willige, S., Ariëns, R. A. S., Rosing, J., Bertina, R. M., Castoldi, E.

    Published in Journal of thrombosis and haemostasis (01-09-2013)
    “…Summary Background Besides its role in blood clotting, fibrinogen exerts a poorly understood anticoagulant function by binding thrombin and modulating its…”
    Get full text
    Journal Article
  20. 20